Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.50 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3503495 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3288792 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1265010 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3501621 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL247007 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3503524 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3503187 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL2559740 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1060504 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1065093 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107636158-B | Biocatalytic oxidation | 赢创运营有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-109593045-B | Preparation method of 11-aminoundecanoic acid | 北京旭阳科技有限公司 | 2021-10-01 | — | — | CN | disclosed |
| EP-2560987-B1 | BIOCATALYTICAL OXIDATION PROCESS WITH ALKL GENE PRODUCT | EVONIK DEGUSSA GMBH (DE) | 2019-02-20 | — | — | EP | disclosed |
| US-20160145242-A1 | PHENYLIMIDAZOLE DERIVATIVE, AND THERAPEUTIC MEDICINE OR PREVENTIVE MEDICINE FOR INFLAMMATORY DISEASE, ETC. | NIPPON SODA CO., LTD. (JP) | 2016-05-26 | — | — | US | disclosed |
| EP-2998298-A1 | PHENYLIMIDAZOLE DERIVATIVE, AND THERAPEUTIC MEDICINE OR PREVENTIVE MEDICINE FOR INFLAMMATORY DISEASE, ETC. | Nippon Soda Co., Ltd. (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-20150191607-A1 | Anti-fouling Paints and Coatings | REACTIVE SURFACES, LTD (US) | 2015-07-09 | — | — | US | disclosed |
| EP-2560987-A1 | BIOCATALYTIC OXIDATION PROCESS WITH ALKL GENE PRODUCT | Evonik Degussa GmbH (DE) | 2013-02-27 | — | — | EP | disclosed |
| US-8372981-B2 | Nitrogen-containing aromatic derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2013-02-12 | — | — | US | disclosed |
| US-8367666-B2 | 3-carbamoyl-2-pyridone derivatives | SHIONOGI & CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20120208813-A1 | 3-CARBAMOYL-2-PYRIDONE DERIVATIVES | SHIONOGI & CO., LTD. | 2012-08-16 | — | — | US | disclosed |
| US-4409141-A | Peptides for assaying human parathyroid hormone | TOYO JOZO KABUSHIKI KAISHA (JP) | 1983-10-11 | — | — | US | disclosed |
| US-4238473-A | LOWER CARBOHYDRATES HAVING A BRIDGING ARM GLYCOSIDICALLY LINKED TO AN ALDOSE MOIETY | CHEMBIOMED LIMITED (CA) | 1980-12-09 | — | — | US | disclosed |
| US-RE30287-E | TREATMENT OF BRONCHIAL ASTHMA | GIST-BROCADES N.V. (NL) | 1980-05-27 | — | — | US | disclosed |
| US-4190670-A | BRONCHODILATORS | GIST BROCADES N.V. (NL) | 1980-02-26 | — | — | US | disclosed |
| US-4137401-A | Glycoside-ether-ester compounds | CHEMBIOMED LIMITED (CA) | 1979-01-30 | — | — | US | disclosed |
| US-4058551-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1977-11-15 | — | — | US | disclosed |
| US-4042606-A | PROSTAGLANDIN ENANTIOMORPHS | THE UPJOHN COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
| US-3962289-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3932486-A | GASTRIC SECRETION INHIBITORS, ANTISPASMODIC, ANTIASTHMATIC, HYPOTENSIVE | THE UPJOHN COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931281-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208813-A1 | 3-CARBAMOYL-2-PYRIDONE DERIVATIVES | CNR2, CNR1, HRH4 | CYP1A2 1314/4885DGKA 498/4885ALDH1A1 3505/4885 |
| US-20160145242-A1 | PHENYLIMIDAZOLE DERIVATIVE, AND THERAPEUTIC MEDICINE OR PREVENTIVE MEDICINE FOR INFLAMMATORY DISEASE, ETC. | ALDH1A2, ARG2, NR1I2 | CYP1A2 158/4885DGKA 3729/4885ALDH1A1 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.